arrow
N

Nan Bi

北京协和医学院
H指数:36
被引数:5,290

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early stage nonsmall cell lung cancer: Toward a risk-adaptive paradigm in the era of biologic precision

早期非小细胞肺癌:在生物精准时代迈向风险适应性范式

2026-09-100
OAAI
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trial

S-1为基础的放化疗在不可手术的老年食管癌患者中的长期疗效:一项多中心、随机、III期临床试验

2025-12-160
PRE
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy

PACIFIC-5: 在不可切除的III期NSCLC患者中巩固durvalumab的III期临床试验,同时或序贯放化疗后无进展

2025-12-070
OAAI
Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patients✰

III期非小细胞肺癌携带ALK重排的长期结局与临床特征:一项包含176例患者的多中心回顾性研究✰

2025-11-270
OAAI
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial

吡非尼酮治疗2级和3级放射性肺损伤:一项多中心、开放标签、随机、二期试验

2025-11-060
PRE
Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients

循环肿瘤DNA为局限期小细胞肺癌患者的巩固性免疫治疗提供优化方案

2025-10-160
OA
Long-term outcomes of postoperative radiotherapy for patients with pIIIA-N2 non-small-cell lung cancer after complete resection and adjuvant chemotherapy (PORT-C): a single-centre, randomized, phase 3 trial

术后放疗对完全切除并接受辅助化疗的pIIIA-N2非小细胞肺癌患者长期结局的影响(PORT-C):一项单中心、随机、III期试验

2025-10-160
OAAI
Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial

同步整合推量调强放射治疗联合或不联合同期化疗在食管鳞状细胞癌患者中的应用:一项多中心、开放标签、随机、III期临床试验

2025-10-150
PRE
Simultaneous Integrated Dose Reduction Radiotherapy Versus Conventional Fractionated Radiotherapy With Chemotherapy for Limited-Stage Small-Cell Lung Cancer in the Modern Treatment Era: a Phase III, Randomized Clinical Trial (SDR-RT trial)

同步整合剂量降低放射疗法与常规分割放射疗法联合化疗治疗现代治疗时代局限期小细胞肺癌的随机III期临床试验(SDR-RT试验)

2025-10-140
PRE